Skip to content
The Policy VaultThe Policy Vault

Glumetza — Blue Cross Blue Shield of Texas

other indications supported in compendia for the requested agent and route of administration

Preferred products

  • Metformin HCl Tab ER 24HR Osmotic 500 MG
  • Metformin HCl Tab ER 24HR Osmotic 1000 MG
  • metformin hcl tab 750 MG
  • Metformin HCl Tab 625 MG

Initial criteria

  • 1. ONE of the following: A. The patient has a diagnosis of type 2 diabetes mellitus OR B. The patient has another FDA labeled indication for the requested agent and route of administration OR C. The patient has another indication that is supported in compendia for the requested agent and route of administration AND
  • 2. ONE of the following: A. The request is for a BCBS IL Fully Insured, HIM, or Non-ERISA ASO/Self-insured Municipalities/Counties member OR B. The patient is currently being treated with the requested agent and the patient is currently stable on the requested agent OR C. The patient has tried and had an inadequate response to ONE non-targeted generic metformin product OR D. ONE non-targeted generic metformin product was discontinued due to lack of efficacy or effectiveness, diminished effect, or an adverse event OR E. The patient has an intolerance or hypersensitivity to ONE non-targeted generic metformin product that is not expected to occur with the requested agent OR F. The patient has an FDA labeled contraindication to ALL non-targeted generic metformin products that is not expected to occur with the requested agent OR G. ONE non-targeted generic metformin product is expected to be ineffective based on known clinical characteristics of the patient and known characteristics of the prescription drug; OR cause a significant barrier to the patient’s adherence of care; OR worsen a comorbid condition; OR decrease the patient’s ability to achieve or maintain reasonable functional ability in performing daily activities; OR cause an adverse reaction or cause physical or mental harm OR H. ONE non-targeted generic metformin product is not in the best interest of the patient based on medical necessity OR I. The patient has tried another prescription drug in the same pharmacologic class or with the same mechanism of action as ONE non-targeted generic metformin product and that prescription drug was discontinued due to lack of efficacy or effectiveness, diminished effect, or an adverse event OR J. If the patient has diabetes, then the requested agent is medically necessary and appropriate for the patient AND
  • 3. The patient does NOT have any FDA labeled contraindication(s) to the requested agent